ArticleTransplantation proceedings2022

Analysis of Risk Factors for a Low Immune Response to Messenger RNA COVID-19 Vaccine in Kidney Transplant Recipients and Differences Between Second and Third Dose.

A Panarese et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.